Australian Clinical Labs Ltd Capital Reinvestment Ratio
Australian Clinical Labs Ltd capital reinvestment ratio. Australian Clinical Labs Ltd (ACL) has a Capital Reinvestment Ratio of 0.06x as of December 2025, meaning it reinvests 0% of its operating cash flow (AU$62.87 Million) in capital expenditures (AU$3.47 Million). Check Australian Clinical Labs Ltd (ACL) reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Australian Clinical Labs Ltd (2016–2025)
Capital reinvestment ratio of Australian Clinical Labs Ltd from 2016 to 2025. This chart tracks Australian Clinical Labs Ltd's Capital Reinvestment Ratio across 18 annual periods. Also explore Australian Clinical Labs Ltd (ACL) net asset momentum to track the company's year-over-year net asset growth rate.
Australian Clinical Labs Ltd Capital Reinvestment Ratio by Year (2016–2025)
Australian Clinical Labs Ltd capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see ACL cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (AUD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.05x | AU$182.80 Million | AU$8.41 Million | ▲ +0.0% |
| 2024 | 0.05x | AU$182.80 Million | AU$8.41 Million | ▲ +12.9% |
| 2024 | 0.04x | AU$159.59 Million | AU$6.50 Million | ▲ +0.0% |
| 2023 | 0.04x | AU$159.59 Million | AU$6.50 Million | ▼ -15.5% |
| 2023 | 0.05x | AU$143.68 Million | AU$6.93 Million | ▲ +0.0% |
| 2022 | 0.05x | AU$143.68 Million | AU$6.93 Million | ▼ -35.5% |
| 2022 | 0.07x | AU$284.09 Million | AU$21.25 Million | ▲ +0.0% |
| 2021 | 0.07x | AU$284.09 Million | AU$21.25 Million | ▲ +21.1% |
| 2021 | 0.06x | AU$153.86 Million | AU$9.51 Million | ▲ +0.0% |
| 2020 | 0.06x | AU$153.86 Million | AU$9.51 Million | ▼ -33.0% |
| 2020 | 0.09x | AU$101.74 Million | AU$9.38 Million | ▲ +0.0% |
| 2019 | 0.09x | AU$101.74 Million | AU$9.38 Million | ▼ -99.3% |
| 2019 | 12.92x | AU$1.11 Million | AU$14.36 Million | ▲ +0.0% |
| 2018 | 12.92x | AU$1.11 Million | AU$14.36 Million | ▲ +601.9% |
| 2018 | 1.84x | AU$4.69 Million | AU$8.63 Million | ▲ +0.0% |
| 2017 | 1.84x | AU$4.69 Million | AU$8.63 Million | ▲ +13.6% |
| 2017 | 1.62x | AU$4.60 Million | AU$7.46 Million | ▲ +0.0% |
| 2016 | 1.62x | AU$4.60 Million | AU$7.46 Million | — |